Myocardial infarction (MI). ST elevation (STEMI) myocardial infarction
Conditions
Interventions
Intervention 1: Intervention group: Telmisartan. Intervention 2: Intervention group: Valsartan.
Sponsors
Qazvin University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 80 Years
Inclusion criteria
Inclusion criteria: patients with STEMI Abdicación clases 1 for ACE OR ARB
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lipid profile including total cholesterol, low-density lipoprotein (LDL), high-density lipoprotein (HDL), and triglycerides. Timepoint: 3 m after starting the medication. Method of measurement: Blood sampling and serum testing with a standard blood biochemistry analyzer.;Serum creatinine level and glomerular filtration rate (GFR) indicating kidney function. Timepoint: Before starting the medication and 3 m after starting the medication. Method of measurement: Blood sample and serum analysis with standard device. | — |
Secondary
| Measure | Time frame |
|---|---|
| Systolic and diastolic blood pressure of patients. Timepoint: Before starting the medication, 4 weeks after starting the medication. Method of measurement: Standard mercury sphygmomanometer.;Body mass index (BMI) of patients. Timepoint: Before starting the medication, 4 weeks after starting the medication. Method of measurement: Measuring height and weight with a standard scale and tape measure.;Fasting blood glucose level. Timepoint: Before starting the medication, 4 weeks after starting the medication. Method of measurement: Blood sample and serum test with standard blood biochemistry analyzer.;Adverse drug reactions. Timepoint: During the treatment period. Method of measurement: Questionnaire and clinical interview. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohamad taghi pour
Qazvin University of Medical Sciences
Outcome results
None listed